Antibiotic Susceptibility Pattern of Gram-positive Cocci Cultured from Patients in Three University Hospitals in Tehran, Iran during 2001-2005
-
Marzieh Aligholi
,
Mohammad Emaneini
,
Fereshteh Jabalameli
,
Shadi Shahsavan
,
Zohreh Abdolmaleki
,
Hossein Sedaghat
,
Nematollah Jonaidi
Abstract
Bacterial resistance to antibiotics is a serious problem and is increasing in prevalence world-wide at an alarming rate. The antimicrobial susceptibility patterns of 1897 gram-positive bacterial Isolates were evaluated. The minimum inhibitory concentration (MIC) of isolates which comprised Staphylococcus aureus (927 isolates), coagulase-negative staphylococci (CNS; 425 isolates), Enterococcus faecalis (320 isolates), Enterococcus faecium (157 isolates), and pneumococci (50 isolates) collected from 3 teaching hospitals in Tehran were determined by agar dilution method according to Clinical and Laboratory Standards Institute (CLSI) guidelines. The presence of mecA gene was investigated in methicillin-resistant staphylococci by PCR method and vanA and vanB genes were targeted in enterococcal isolates by Multiplex PCR method. The resistance rate to methicillin among S. aureus and CNS isolates were 33% and 49%, respectively. All S. aureus isolates were susceptible to vancomycin .The lowest rate of resistance in all S. aureus isolates was found for rifampicin (<4%). The vancomycin resistance rate in enterococci isolates was 11% which was more frequent among E. faecium (19%) than E. faecalis (4%), all resistant isolates carrying vanA. High-level resistance to gentamicin and streptomycin, were detected in 47% and 87% of enterococcal isolates respectively. The rate of penicillin resistance in pneumococci was 3% and about 27% of isolates had reduced susceptibility to penicillin. The prevalence of erythromycin resistant among pneumococci was 58%. All pneumococcal isolates were susceptible to ceftriaxone, rifampicin and vancomycin. Our data highlight the importance of access to updated bacterial susceptibility data regarding commonly prescribed agents for clinicians in Iran.
Jeljaszewicz J, Mlynarczyk G, Mlynarczyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Agents 2000; 16(4): 473-8.
Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 2006; 34(5 Suppl 1): S11-9.
A Report from the National Nosocomial Infections Surveillance (NNIS) System. Nosocomial infection rates for interhospitalcomparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991; 12(10): 609-21.
A report from the NNIS System. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997. Am J Infect Control 1997; 25(6): 477-87.
Pezzlo M. Aerobic bacteriology. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology (ASM Press); 1992. p. 1. 19. 20. 47.
Reisner SB, Woods GL, Thomson RP Jr, Larone DH, Garcia LS, Shimuzu RY. Specimen collection. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology (ASM Press) 1999; p. 64-76.
National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Wayne, PA: NCCLS; 2004.
Sahm DF, Peterson DE, Critchley IA, Thornsberry C. Analysis of ciprofloxacin activity against Streptococcuspneumoniae after 10 years of use in the United States. Antimicrob Agents Chemother 2000; 44(9): 2521-4.
Vannuffel P, Gigi J, Ezzedine H, Vandercam B, Delmee M, Wauters G, et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol 1995; 33(11): 2864-7.
Cuevas O, Cercenado E, Vindel A, Guinea J, Sánchez- Conde M, Sánchez-Somolinos M, et al. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother 2004; 48(11): 4240-5.
Madani TA, Al-Abdullah NA, Al-Sanousi AA, Ghabrah TM, Afandi SZ, Bajunid HA. Methicillin-resistant Staphylococcus aureus in two tertiary-care centers in Jeddah, Saudi Arabia. Infect Control Hosp Epidemiol 2001; 22(4): 211-6.
El Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 2003; 51(3): 625-30.
Baddour MM, Abuelkheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob 2006; 5: 30.
Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12(9): 844-52.
Arias CA, Reyes J, Zúñiga M, Cortés L, Cruz C, Rico CL, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003; 51(1): 59-68.
Gales AC, Sader HS, Jones RN. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres. Clin Microbiol Infect 2005; 11(2): 95-100.
Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, et al. Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods. Clin Microbiol Infect 2004; 10(3): 242-6.
Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. J Antimicrob Chemother 2000; 46(6): 931-40.
Schouten MA, Voss A, Hoogkamp-Korstanje JA. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrob Agents Chemother 1999; 43(10): 2542-6.
Guiney M, Urwin G. Frequency and antimicrobial susceptibility of clinical isolates of enterococci. Eur J Clin Microbiol Infect Dis 1993; 12(5): 362-6.
Schmitz FJ, Verhoef J, Fluit AC. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis 1999; 18(6): 414-21.
Udo EE, Al-Sweih N, Phillips OA, Chugh TD. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 2003; 52(Pt 2): 163-8.
Nelson RR, McGregor KF, Brown AR, Amyes SG, Young H. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. J Clin Microbiol 2000; 38(6): 2112-6.
Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit: a European andNorth American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3: 14.
Feizabadi MM, Asadi S, Aliahmadi A, Parvin M, Parastan R, Shayegh M, et al. Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. Int J Antimicrob Agents 2004; 24(5): 521-2.
Fatholahzadeh F, Hashemi FB, Emaneini M, Aligholi M, Nakhjavani FA, and Kazemi B. Detection of Vancomycin Resistant Enterococci (VRE) Isolated From Urinary Tract Infections (UTI) in Tehran, Iran. Daru 2006; 14(3): 141-5.
Bonten MJ, Willems R, Weinstein RA. Vancomycinresistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1(5): 314-25.
Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda= for the future. Emerg Infect Dis 1998; 4(2): 239-49.
Decousser JW, Pina P, Viguier F, Picot F, Courvalin P, Allouch P; ColBVH Study Group. Invasive Streptococcuspneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 2004; 48(9): 3636-9.
European Antimicrobial Resistance Surveillance System. EARSS interactive database access [Online]. 2005 Oct 26. Available from: URL:http://www.earss.rivm.nl/PAGINA/ interwebsite/home_earss.html
Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357(9271): 1851-3.
Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42(7): 1762-70.
| Files | ||
| Issue | Vol 47, No 4 (2009) | |
| Section | Articles | |
| Keywords | ||
| Antimicrobial susceptibility patterns gram-positive Cocci VRE Pneumococci | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
